The Impact of Hypogammaglobulinemia on Infection Outcome in Patients Undergoing Ventricular Assist Device Implantation

Journal of Heart and Lung Transplantation

Volumn 25, Issue 7, 2006, Pages 820-824

  Yamani, Mohamad H ^a   Chuang, Hsuan Hung ^a   Ozduran, Volkan ^a   Avery, Robin K ^a   Mawhorter, Steven D ^a   Cook, Daniel J ^a   Zilka, Cathy ^a   Zeroske, Kimberly ^a   Buda, Tiffany ^a   Hobbs, Robert E ^a   Taylor, David O ^a   Smedira, Nicholas G ^a   Starling, Randall C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; BACTEREMIA; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DEVICE; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMPLANTATION; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGAMMAGLOBULINEMIA; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS; VIREMIA;

EID: 33745502898     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.03.009     Document Type: Article

References (23)

1. Fischer S.A., Trenholme G.M., Costanzo M.R., and Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis 24 (1997) 18-23
2. Smart F.W., Naftel D.C., Costanzo M.R., et al. Risk factors for early, cumulative, and fatal infections after heart transplantation. a multiinstitutional study. J Heart Lung Transplant 15 (1996) 329-341
3. Herrmann M., Weyand M., Greshake B., et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 95 (1997) 814-817
4. Holman W.L., Skinner J.L., Waites K.B., Benza R.L., McGiffin D.C., and Kirklin J.K. Infection during circulatory support with ventricular assist devices. Ann Thorac Surg 68 (1999) 711-716
5. Prendergast T.W., Todd B.A., Beyer III A.J., et al. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg 64 (1997) 142-147
6. Argenziano M., Catanese K.A., Moazami N., et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 16 (1997) 822-831
7. Massad M.G., McCarthy P.M., Smedira N.G., et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?. J Thorac Cardiovasc Surg 112 (1996) 1275-1281 discussion 1282-3
8. Holman W.L., Park S.J., Long J.W., et al. Infection in permanent circulatory support. experience from the REMATCH trial. J Heart Lung Transplant 23 (2004) 1359-1365
9. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
10. Itescu S., Ankersmit J.H., Kocher A.A., and Schuster M.D. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis 43 (2000) 67-80
11. Itescu S., and John R. Interactions between the recipient immune system and the left ventricular assist device surface. immunological and clinical implications. Ann Thorac Surg 75 (2003) S58-S65
12. Schuster M., Kocher A., Lietz K., et al. Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. Transplant Proc 33 (2001) 1960-1961
13. Schuster M., Ankersmit J., Kocher A., et al. Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation. Transplant Proc 33 (2001) 1958-1959
14. John R., Lietz K., Schuster M., et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125 (2003) 578-591
15. Ankersmit H.J., Edwards N.M., Schuster M., et al. Quantitative changes in T-cell populations after left ventricular assist device implantation. relationship to T-cell apoptosis and soluble CD95. Circulation 100 19 Suppl (1999) II211-II215
16. Ankersmit H.J., Tugulea S., Spanier T., et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354 (1999) 550-555
17. Yamani M.H., Avery R.K., Mawhorter S.D., et al. Hypogammaglobulinemia following cardiac transplantation. a link between rejection and infection. J Heart Lung Transplant 20 (2001) 425-430
18. Thaler S.J., and Rubin R.H. Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol 11 (1996) 191-203
19. Yamani M.H., Avery R., Mawhorter S., et al. Hypogammaglobulinemia after heart transplantation. impact of preemptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transpl Infect Dis 3 Suppl 2 (2001) 40-43
20. Rothenburger M., Wilhelm M., Hammel D., et al. Immune response in the early postoperative period after implantation of a left-ventricular assist device system. Transplant Proc 33 (2001) 1955-1957
21. Erren M., Schluter B., Fobker M., et al. Immunologic effects of implantation of left ventricular assist devices. Transplant Proc 33 (2001) 1965-1968
22. Corales R., Chua J., Mawhorter S., et al. Significant posttransplant hypogammaglobulinemia in six heart transplant recipients. an emerging clinical phenomenon?. Transpl Infect Dis 2 (2000) 133-139
23. von Haehling S., Jankowska E.A., Okonko D.O., Strohschein K., Doehner W., and Anker S.D. Diminished T helper and B cell numbers and attenuated antigen presentation capacity in chronic heart failure. J Am Coll Cardiol 45 (2005) 177A